Victory Capital Management Inc Immuno Gen, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$12.46 - $29.95 $1.32 Million - $3.16 Million	-105,633 Reduced 75.0%	35,213 $1.04 Million
Q3 2023 Nov 06, 2023	BUY	$14.09 - $19.87 $273,613 - $385,855	19,419 Added 15.99%	140,846 $2.24 Million
Q2 2023 Jul 27, 2023	BUY	$3.75 - $20.05 $361,323 - $1.93 Million	96,353 Added 384.27%	121,427 $2.29 Million
Q1 2023 May 02, 2023	BUY	$3.67 - $4.92 $1,009 - $1,353	275 Added 1.11%	25,074 $96,000
Q4 2022 Feb 10, 2023	BUY	$4.55 - $6.31 $1,023 - $1,419	225 Added 0.92%	24,799 $123,000
Q4 2022 Feb 09, 2023	SELL	$4.55 - $6.31 $1,073 - $1,489	-236 Reduced 0.95%	24,574 $121,000
Q3 2022 Nov 02, 2022	SELL	$4.48 - $6.47 $17,928 - $25,892	-4,002 Reduced 13.89%	24,810 $119,000
Q2 2022 Aug 01, 2022	SELL	$3.15 - $5.76 $1,597 - $2,920	-507 Reduced 1.73%	28,812 $130,000
Q1 2022 May 04, 2022	BUY	$4.26 - $7.48 $1,422 - $2,498	334 Added 1.15%	29,319 $142,000
Q4 2021 Feb 07, 2022	BUY	$4.75 - $7.5 $3,562 - $5,625	750 Added 2.66%	28,985 $215,000
Q3 2021 Nov 02, 2021	BUY	$5.02 - $6.59 $2,560 - $3,360	510 Added 1.84%	28,235 $160,000
Q2 2021 Aug 03, 2021	SELL	$5.79 - $8.6 $14,162 - $21,035	-2,446 Reduced 8.11%	27,725 $183,000
Q1 2021 May 04, 2021	BUY	$6.5 - $10.53 $6,207 - $10,056	955 Added 3.27%	30,171 $244,000
Q4 2020 Feb 01, 2021	BUY	$3.7 - $7.66 $12,620 - $26,128	3,411 Added 13.22%	29,216 $188,000
Q3 2020 Nov 09, 2020	SELL	$3.45 - $4.89 $5,061 - $7,173	-1,467 Reduced 5.38%	25,805 $93,000
Q2 2020 Aug 07, 2020	SELL	$3.32 - $5.34 $3,638 - $5,852	-1,096 Reduced 3.86%	27,272 $125,000
Q1 2020 May 04, 2020	SELL	$2.12 - $6.8 $16,453 - $52,774	-7,761 Reduced 21.48%	28,368 $97,000
Q4 2019 Feb 06, 2020	BUY	$2.25 - $5.8 $17,194 - $44,323	7,642 Added 26.83%	36,129 $184,000
Q4 2019 Feb 04, 2020	BUY	$2.25 - $5.8 $7,762 - $20,010	3,450 Added 13.78%	28,487 $135,000
Q3 2019 Nov 12, 2019	BUY	$2.22 - $3.39 $55,582 - $84,875	25,037 New	25,037 $61,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account